Report copyright - SGLT2選択的阻害剤の創薬研究 - Kotobuki …...Section Chief, Research Laboratories, Kotobuki Pharmaceutical Co., Ltd. *5 寿製薬株式会社代表取締役社長 President,
Please pass captcha verification before submit form
Please pass captcha verification before submit form